Abstract: . . .  10%). The data clearly demonstrate that the RHASP target of at least halving event rates in high-risk cardiovascular patients, through evidence-based prescribing of cardio-protective medication and by reducing and maintaining average reductions in blood pressure of 12/8 mmHg and in cholesterol of 0.8 mmol/l, together with life-style changes is realistic and achievable. On this basis, it is possible to estimate that if 20,000 high-risk patients in the Eastern Regional . . .
. . .  achievable. On this basis, it is possible to estimate that if 20,000 high-risk patients in the Eastern Regional Health Authority were managed within the RHASP program over a 10-year period, this would result in the prevention of 1,500 heart attacks and 750 strokes. The ICT Aspects 1. The information and communications technology underpinning the RHASP model have quality, user friendliness and technical merit (including data security) not just for cardiovascular . . .
. . .  On this basis, it is possible to estimate that if 20,000 high-risk patients in the Eastern Regional Health Authority were managed within the RHASP program over a 10-year period, this would result in the prevention of 1,500 heart attacks and 750 strokes. The ICT Aspects 1. The information and communications technology underpinning the RHASP model have quality, user friendliness and technical merit (including data security) not just for cardiovascular . . .
. . .  other management programs - dabl Ambulatory Blood Pressure, for the analysis of 24-hour blood pressure, dabl Anticoagulant for managing patients on the anticoagulant drug warfarin, and dabl Diabetes is being developed for managing  . . .
. . .  basis, it is possible to estimate that if 20,000 high-risk patients in the Eastern Regional Health Authority were managed within the RHASP program over a 10-year period, this would result in the prevention of 1,500 heart attacks and 750 strokes. The ICT Aspects 1. The information and communications technology underpinning the RHASP model have quality, user friendliness and technical merit (including data security) not just for cardiovascular disease management . . .
. . .  disease event within 10 years - high (risk greater or equal to 20%), medium (risk 10 20%) and low (risk less than 10%). The data clearly demonstrate that the RHASP target of at least halving event rates in high-risk cardiovascular patients, through evidence-based prescribing of cardio-protective medication and by reducing and maintaining average reductions in blood pressure of 12/8 mmHg and in cholesterol of 0.8 mmol/l, together with life-style changes is realistic and . . .
--3000,6,250,3292,64609